Solid-organ transplantation is a life-saving treatment for end-stage organ disease in highly
selected patients. Alongside the tremendous progress in the last several decades, new …

The number of Americans 65 years or older in 2060 will be more than double what it was in
2014. Approximately 40% of patients seen in gastroenterology (GI) and hepatology practices …

Objective: To determine if the association of frailty and waitlist mortality varies by candidate
age. Background: Frailty, a construct developed in geriatrics, is a state of decreased …

Postoperative atrial fibrillation/flutter (POAF) is the most common perioperative arrhythmia
and may be particularly problematic after liver transplantation (LT). This study is a single …

Aim The global burden of chronic liver disease is substantial. Limited studies have reported
the prevalence of metabolic dysfunction‐associated fatty liver disease (MAFLD) and liver …

Livers from older donors (OLDs; age≥ 70) are risky and often declined; however, it is likely
that some candidates will benefit from OLDs versus waiting for younger ones. To …

Hepatocellular carcinoma (HCC) is the fastest‐rising cause of cancer‐related mortality in the
United States and is a leading indication for liver transplantation (LT). Changes have been …

Patients with advanced liver disease and their families have unique and complex physical,
psychological, psychosocial, and existential care needs. They experience a high symptom …

Background. The global surge in aging has intensified debates on liver transplantation (LT)
for candidates aged 75 y and older, given the prevalent donor scarcity. This study examined …

Liver transplantation continues be the standard for treatment of end-stage liver disease, and
even with recent advances in organ preservation, the anesthetic management continues to …